Juvenile myelomonocytic leukemia medical therapy
Juvenile myelomonocytic leukemia Microchapters |
Differentiating Juvenile myelomonocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Juvenile myelomonocytic leukemia medical therapy On the Web |
American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia medical therapy |
Juvenile myelomonocytic leukemia medical therapy in the news |
Risk calculators and risk factors for Juvenile myelomonocytic leukemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There is no internationally accepted treatment protocol for JMML. Currently, 2 clinical treatment protocols most widely used to study JMML and improve treatment for these children are geographically-based:
- North America: The Children’s Oncology Group (COG) JMML Study
- Europe: The European Working Group for Myelodysplastic Syndromes (EWOG-MDS) JMML Study
- Other clinical trials open to patients with JMML may be searched for at the NIH Clinical Trials website.
The following procedures are used in one or both of the current clinical trials listed above: